Literature DB >> 8198349

Antiendotoxin antibodies: a dead end?

A S Cross.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8198349     DOI： 10.7326/0003-4819-121-1-199407010-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  10 in total

1.  Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum.

Authors:  J Hellman; P M Loiselle; M M Tehan; J E Allaire; L A Boyle; J T Kurnick; D M Andrews; K Sik Kim; H S Warren
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Fair and effective resource allocation in cancer care: uncharted territory?

Authors:  J A Green; C Williams; A Cribb; B Brecher; M Evans
Journal:  Health Care Anal       Date:  1996-02

Review 3.  Development trends for human monoclonal antibody therapeutics.

Authors:  Aaron L Nelson; Eugen Dhimolea; Janice M Reichert
Journal:  Nat Rev Drug Discov       Date:  2010-09-03       Impact factor: 84.694

4.  Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.

Authors:  Catherine H Valentine; Judith Hellman; Laura K Beasley-Topliffe; Aranya Bagchi; H Shaw Warren
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

5.  A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis.

Authors:  Y Suputtamongkol; S Intaranongpai; M D Smith; B Angus; W Chaowagul; C Permpikul; J A Simpson; A Leelarasamee; L Curtis; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria.

Authors:  S A David; R Silverstein; C R Amura; T Kielian; D C Morrison
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

7.  Binding to and opsonophagocytic activity of O-antigen-specific monoclonal antibodies against encapsulated and nonencapsulated Klebsiella pneumoniae serotype O1 strains.

Authors:  T K Held; N R Jendrike; T Rukavina; R Podschun; M Trautmann
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

8.  Outer membrane vesicles as molecular biomarkers for Gram-negative sepsis: Taking advantage of nature's perfect packages.

Authors:  Lea Vacca Michel; Thomas Gaborski
Journal:  J Biol Chem       Date:  2022-09-13       Impact factor: 5.486

Review 9.  Bacteraemia in the very old. Features and treatment.

Authors:  L Leibovici
Journal:  Drugs Aging       Date:  1995-06       Impact factor: 3.923

Review 10.  Engineering Antibodies for the Treatment of Infectious Diseases.

Authors:  Gaowei Fan; Jinming Li
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.